Choroideremia Research
Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.
Related Articles
Recently@Retina Newsletter February 2024 Chance Encounter Leads to Early Diagnosis and Treatment for Kate The Retina Foundation Hosts Eye On Innovation, The Series, to Discuss Transforming Dallas Health – The Legacy of T. Boone Pickens. Early Detection is Critical for Rare Eye Diseases Anonymous One Million Dollar Gift Given to Retina Foundation for AMD Research